missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18515615

CD109 Antibody (B-E47), DyLight 680, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-18101FR

3364.00 SEK valid until 2025-03-28
Use promo code "25306" to get your promotional price.

Product Code. 18515615

  • 4205.00 SEK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

CD109 Monoclonal antibody specifically detects CD109 in Human samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD109
Monoclonal
DyLight 680
150 kDa TGF-beta-1-binding protein, activated T-cell marker CD109, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7, CD109 antigen, CD109 antigen (Gov platelet alloantigens), CD109 molecule, CPAMD7r150, DKFZp762L1111, FLJ38569, FLJ41966, Gov platelet alloantigens, p180, Platelet-specific Gov antigen, RP11-525G3.1
Eahy 926 cell line. Hybridoma: Myeloma X63/AG.8653 x Balb/c spleen cells
0.1 mL
Cancer, Cell Biology, Cytokine Research, Immunology, Stem Cell Markers
135228
Store at 4°C in the dark.
IgG1 κ
Flow Cytometry
B-E47
50mM Sodium Borate
Mouse
Affinity purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.